Journal of pain and symptom management
-
J Pain Symptom Manage · Feb 2018
Randomized Controlled Trial Multicenter StudyResults of a Double-Blind, Randomized, Placebo-Controlled Study of Nabiximols Oromucosal Spray as Adjunctive Therapy in Advanced Cancer Patients With Chronic Uncontrolled Pain.
Prior Phase 2/3 studies found that cannabinoids might provide adjunctive analgesia in advanced cancer patients with uncontrolled pain. ⋯ Nabiximols might have utility in patients with advanced cancer who receive a lower opioid dose, such as individuals with early intolerance to opioid therapy.
-
J Pain Symptom Manage · Feb 2018
Letter Multicenter StudyClinical Variety may help prevent Burnout after a Decade in Palliative Care.